GH1 and dementia: More specifically, dementia affecting the performance of daily activities was observed with a latency of three to four decades among most young individuals examined with a history of prior hGH administration, while MCI predominantly affecting the patient’s personality and behavior, subjective cognitive symptoms only, or complete absence of symptoms were reported among the remaining individuals.